WA4STEAM
VC Fund
Barcelona, Spain
WA4STEAM is a VC fund in Barcelona focused on Health Care and Biotechnology. Women Angels for STEAM - Supporting women startups worldwide
- Total investments:
- 22
- Last investment:
- Lead investor:
- 23%
Last updated:
For AI agents: llms.txt
Industries WA4STEAM invests in
Stages WA4STEAM invests in
Countries WA4STEAM invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $392k–$4.2M
- Pre-Seed
- $671k–$1.2M
- Venture - Series Unknown
- $6.1M–$11M
Investment Focus
Industry
- Health Care 8 (36%)
- Biotechnology 4 (18%)
- Artificial Intelligence 4 (18%)
- Medical Device 3 (14%)
- Health Diagnostics 3 (14%)
Stage
- Seed 14 (64%)
- Pre-Seed 2 (9%)
- Venture - Series Unknown 2 (9%)
- Series A 1 (5%)
- Funding Round 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Amparo Pazos
Business Angel
|
Business Angel | Total investments: 0 | Find email | |
Pilar Gil
Partner
|
Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Onalabs develops remote, continuous and non-invasive bio-medical devices to monitor through the skin and sweat several vital signs and some biomarkers. Onalabs is the first non-invasive device able to measure some chemical parameters present in sweat using miniaturised biosensors. Its non-invasive products based on wearable formats empower thepatients and their families to measure relevant vital signs and biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier management strategies, resulting in shorter hospital stays and prevention of unnecessary treatments. The solutions are addressed to chronic patients, such as COPD, HF and Diabetes. | $10.6M / Venture - Series Unknown / Jul 24, 2026 | ||
| Hair Up Laser is a plattform specializing in medical products for the treatment of alopecia. | $1M / Seed / Nov 24, 2025 | ||
| Evidence-based microbiome company aims to leverage the central role of probiotics and the gut microbiota on the glycemic regulation. "Microbiota" "Premium probiotics" "Long-term glycemic regulation" "Prediabetes" | $544.1K / Seed / Feb 11, 2025 | ||
| Break-Event aids music industry professionals and businesses by transforming information into knowledge. They are dedicated to providing the product, enabling customers to make wiser decisions, and ensuring the performance of events. | $910.8K / Jan 30, 2025 | ||
| Lawwwing provides a distinctive solution in the market for website compliance. It's a platform that automatically adapts your website or online store to regulations, keeping it up-to-date and personalized. | $391.9K / Seed / Jul 14, 2024 | ||
| IENAI SPACE develops efficient ionic-liquid electric propulsion systems and mission analysis for nano-satellites. The company provides propulsion modules customized for each particular platform and mission, from 2U to 12U, from RAAN-spacing to Earth-Moon transits or de-orbiting.Its versatile Tailored Taylor Thruster is highly scalable in specificimpulse and thrust. It is based on a novel iteration of electrospray thrusters, which boast high theoretical efficiencies for electric propulsion technologies in the low power range. In combination with its decreased form factor, meaning less propellant on-board, making this technology attractive in constrained volumes.IENAI SPACE was founded in 2019 and is headquartered in Madrid, Spain. | $4.2M / Seed / Jun 06, 2024 | ||
| Sustainable proteins from algal waste and invasive biomass | $1.2M / Pre-Seed / Mar 18, 2024 | ||
| MiMARK specializes in developing in vitro diagnostic solutions to improve the management of gynecological malignancies. The company envisions the gynecological fluid as the next step in liquid biopsy in gynecology. MiMARK 's first objective is to improve endometrial cancer diagnosis. | $4.2M / Seed / Nov 27, 2023 | ||
| ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer. | $6.1M / Venture - Series Unknown / Jul 19, 2023 | ||
| Exheus tells everything that you need to know to take maximum care of yourself and avoid risks to your health, exheus is much more than a DNA test that only indicates which genes you have. | $671.1K / Pre-Seed / Nov 29, 2022 | ||
| See all 22 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does WA4STEAM invest in?
WA4STEAM invests primarily in Health Care, Biotechnology and Artificial Intelligence startups, most often at Seed and Pre-Seed stage. Most of the 22 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is WA4STEAM's check size?
WA4STEAM typically joins rounds of $392k–$4.2M at Seed, $671k–$1.2M at Pre-Seed and $6.1M–$11M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds WA4STEAM participates in.
How do I contact WA4STEAM?
Public channels for WA4STEAM include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at WA4STEAM?
The team at WA4STEAM includes Amparo Pazos (Business Angel) and Pilar Gil (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
